Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multilineage dysplasia as assessed by immunophenotype has no impact on clinical-biological features and outcome of NPM1-mutated acute myeloid leukemia.
Mannelli F, Ponziani V, Bonetti MI, Bencini S, Cutini I, Gianfaldoni G, Scappini B, Pancani F, Rondelli T, Benelli M, Caporale R, Grazia Gelli AM, Peruzzi B, Longo G, Bosi A. Mannelli F, et al. Among authors: scappini b. Exp Hematol. 2015 Oct;43(10):869-879.e22. doi: 10.1016/j.exphem.2015.06.003. Epub 2015 Jun 20. Exp Hematol. 2015. PMID: 26101160 Free article.
Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in acute myeloid leukemia.
Mannelli F, Gianfaldoni G, Bencini S, Piccini M, Cutini I, Bonetti MI, Scappini B, Pancani F, Ponziani V, Chiarini M, Borlenghi E, Bassan R, Rossi G, Bosi A. Mannelli F, et al. Among authors: scappini b. Am J Hematol. 2020 Nov;95(11):1304-1313. doi: 10.1002/ajh.25942. Epub 2020 Aug 19. Am J Hematol. 2020. PMID: 32697337 Free article. Clinical Trial.
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia.
Mannelli F, Cutini I, Gianfaldoni G, Bencini S, Scappini B, Pancani F, Ponziani V, Bonetti MI, Biagiotti C, Longo G, Bosi A. Mannelli F, et al. Among authors: scappini b. Cytometry B Clin Cytom. 2014 Jan 24. doi: 10.1002/cytob.21156. Online ahead of print. Cytometry B Clin Cytom. 2014. PMID: 24458841 Free article.
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia.
Mannelli F, Cutini I, Gianfaldoni G, Bencini S, Scappini B, Pancani F, Ponziani V, Bonetti MI, Biagiotti C, Longo G, Bosi A. Mannelli F, et al. Among authors: scappini b. Cytometry B Clin Cytom. 2014 Sep;86(5):340-9. doi: 10.1002/cyto.b.21156. Epub 2014 Feb 5. Cytometry B Clin Cytom. 2014. PMID: 24500843 Free article.
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life.
Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P, Donelli A, Filippi M, Guerrasio A, Gualandi F, La Nasa G, Murialdo A, Pagliai F, Papineschi F, Scappini B, Marmont AM. Saccardi R, et al. Among authors: scappini b. Blood. 2005 Mar 15;105(6):2601-7. doi: 10.1182/blood-2004-08-3205. Epub 2004 Nov 16. Blood. 2005. PMID: 15546956 Free article.
Concomitant occurrence of BCR-ABL and JAK2V617F mutation.
Pieri L, Spolverini A, Scappini B, Occhini U, Birtolo S, Bosi A, Albano F, Fava C, Vannucchi AM. Pieri L, et al. Among authors: scappini b. Blood. 2011 Sep 22;118(12):3445-6. doi: 10.1182/blood-2011-07-365007. Blood. 2011. PMID: 21940831 Free article. No abstract available.
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients.
Bocchia M, Galimberti S, Aprile L, Sicuranza A, Gozzini A, Santilli F, Abruzzese E, Baratè C, Scappini B, Fontanelli G, Trawinska MM, Defina M, Gozzetti A, Bosi A, Petrini M, Puccetti L. Bocchia M, et al. Among authors: scappini b. Oncotarget. 2016 Nov 1;7(44):72311-72321. doi: 10.18632/oncotarget.11100. Oncotarget. 2016. PMID: 27527867 Free PMC article.
47 results